Inside Precision Medicine April 1, 2024
Kathy Vuksanaj

By Larissa Warneck-Silvestrin

July 24th of 2006. It’s a date that you never forget.”

On that fateful Monday, Sharon King and her husband were told by a geneticist that their seven-year-old daughter, Taylor, had a rare genetic disease. They asked the geneticist what they could do and where to seek help.

“He shook his head and said, ‘This is such a rare disease, there is not much you’re going to be able to do in her lifetime and very likely your own’,” Sharon King, manager of advocacy and community engagement at Aldevron and co-founder and president of Taylor’s Tale, told Inside Precision Medicine.

The Kings were advised to take Taylor home and make as many happy memories as possible. But...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
How Americans feel about weight-loss drugs, in 3 charts
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Healthcare supply chain, pharmacy costs to rise in 2025: report

Share This Article